Browse drugs

…nts recruited from the placebo arm will be re-randomised 1:1 to tozorakimab or placebo. The primary endpoint in OBERON, TITANIA and MIRANDA…

… ASU was defined as use of alcohol, tobacco, cannabis, cocaine, heroin, or amphetamines. The primary outcome was 90-day modified Ranki…

…rally). All target MMA vessels were successfully embolized with NeoCast. Distal penetration was achieved in all subjects. Operators wer…

…is (PsA) with a clinical indication for treatment escalation of methotrexate (MTX) (ie, non-response or intolerance to MTX) to a b-DMARD are…

…l. Seven patients discontinued belimumab.Conclusion Progressive belimumab dose spacing and withdrawal, coupled with clinical monitoring, …

…dependent cellular cytotoxicity (ADCC) via an anti-GD2 antibody dinutuximab, and improving NK cell persistence and ADCC by an IL-15 agonist…

…40, using clopidogrel), the LOF-Clopidogrel group (n=309, using clopidogrel), and the LOF-Ticagrelor group (n=105, using ticagrelor). The p…

…ytic therapy with its single bolus administration compared with alteplase. Moreover, its high specificity for fibrin may contribute to a …

… requires adjunctive opioids to suppress coughing and movement. Oliceridine is a G-protein-biased μ-opioid receptor agonist that may provid…

…dy included 314 anti-TNF treatment courses (212 infliximab, 102 adalimumab) in 248 patients at a tertiary centre in the United Arab Emirat…

…44-low HCT15 cells. Cells were treated with blue light alone or A6-Sp-TVP followed by blue light. Cell viability, ROS production, ultrast…

…e in DSS-induced murine model (IDDF2026-ABS-0190 Figure 1(A-F)).Phytosphingosine(PHS) was identified as the specific active component in FPEVs b…